BACKGROUND: There is lack of evidence of the impact of varying season on heart failure (HF) hospitalization outcomes in the U.S. HYPOTHESIS: HF hospitalization outcomes exhibit significant seasonal variation in the U.S. METHODS: Using data from the National Inpatient Sample (2011-2013), seasonal variation was classified based on meteorological classification of Northern Hemisphere-Spring, Summer, Fall, & Winter-and analysis was conducted via multivariable-adjusted mixed-effect model. RESULTS: An estimated 2.8 million adults were hospitalized for HF in the U.S. from 2011 to 2013. Of all hospitalizations, admissions were highest in Winter (27%), followed by Spring (26%), Fall (24%), and Summer (23%). The overall mortality rate was 3.1%. Compared with Spring, there was significantly lower mortality in Summer (odds ratio [OR]: 0.95, 95% CI: 0.91-0.99) and Fall (OR: 0.94, 95% CI: 0.89-0.98), but the highest mortality was in Winter (OR: 1.06, 95% CI: 1.02-1.11). In addition, mean length of stay and median cost of hospitalization were highest in Winter (5.3 days, USD7459, respectively) and lowest in Summer (5.1 days, USD7181, respectively). However, age and sex differences existed (e.g. seasonal variation in inpatient mortality was only significant for patients age ≥65 years, and, compared with the Spring season, males had higher risk of inpatient mortality in Winter (OR: 1.10, 95% CI: 1.04-1.17) and females had lower risk of inpatient mortality in Summer (OR: 0.94, 95% CI: 0.88-1.00) and Fall (OR: 0.92, 95% CI: 0.87-0.98). CONCLUSIONS: Among HF patients in the U.S., hospitalization outcomes were worse in Winter but better in Summer.
BACKGROUND: There is lack of evidence of the impact of varying season on heart failure (HF) hospitalization outcomes in the U.S. HYPOTHESIS: HF hospitalization outcomes exhibit significant seasonal variation in the U.S. METHODS: Using data from the National Inpatient Sample (2011-2013), seasonal variation was classified based on meteorological classification of Northern Hemisphere-Spring, Summer, Fall, & Winter-and analysis was conducted via multivariable-adjusted mixed-effect model. RESULTS: An estimated 2.8 million adults were hospitalized for HF in the U.S. from 2011 to 2013. Of all hospitalizations, admissions were highest in Winter (27%), followed by Spring (26%), Fall (24%), and Summer (23%). The overall mortality rate was 3.1%. Compared with Spring, there was significantly lower mortality in Summer (odds ratio [OR]: 0.95, 95% CI: 0.91-0.99) and Fall (OR: 0.94, 95% CI: 0.89-0.98), but the highest mortality was in Winter (OR: 1.06, 95% CI: 1.02-1.11). In addition, mean length of stay and median cost of hospitalization were highest in Winter (5.3 days, USD7459, respectively) and lowest in Summer (5.1 days, USD7181, respectively). However, age and sex differences existed (e.g. seasonal variation in inpatient mortality was only significant for patients age ≥65 years, and, compared with the Spring season, males had higher risk of inpatient mortality in Winter (OR: 1.10, 95% CI: 1.04-1.17) and females had lower risk of inpatient mortality in Summer (OR: 0.94, 95% CI: 0.88-1.00) and Fall (OR: 0.92, 95% CI: 0.87-0.98). CONCLUSIONS: Among HF patients in the U.S., hospitalization outcomes were worse in Winter but better in Summer.
Authors: Robert O Bonow; Susan Bennett; Donald E Casey; Theodore G Ganiats; Mark A Hlatky; Marvin A Konstam; Costas T Lambrew; Sharon-Lise T Normand; Ileana L Piña; Martha J Radford; Andrew L Smith; Lynne Warner Stevenson; Robert O Bonow; Susan J Bennett; Gregory Burke; Kim A Eagle; Harlan M Krumholz; Costas T Lambrew; Jane Linderbaum; Frederick A Masoudi; Sharon-Lise T Normand; James L Ritchie; John S Rumsfeld; John A Spertus Journal: J Am Coll Cardiol Date: 2005-09-20 Impact factor: 24.094
Authors: Gregg C Fonarow; J Thomas Heywood; Paul A Heidenreich; Margarita Lopatin; Clyde W Yancy Journal: Am Heart J Date: 2007-06 Impact factor: 4.749
Authors: Manuel Martínez-Sellés; José A García Robles; Luis Prieto; José A Serrano; Roberto Muñoz; Elisa Frades; Jesús Almendral Journal: Eur J Heart Fail Date: 2002-12 Impact factor: 15.534
Authors: Sally C Inglis; Robyn A Clark; Sepehr Shakib; Denis T Wong; Payman Molaee; David Wilkinson; Simon Stewart Journal: Eur J Heart Fail Date: 2008-05-20 Impact factor: 15.534
Authors: Jonathan M Wai; Christopher Aloezos; Wenzhu B Mowrey; Sarah W Baron; Regina Cregin; Howard L Forman Journal: J Subst Abuse Treat Date: 2019-01-23
Authors: Lucrecia María Burgos; Lorena Villalba; Rita María Paula Miranda; Andreína Gil Ramírez; Fernando Botto; Mirta Diez Journal: Int J Heart Fail Date: 2021-03-29
Authors: Rachel Wells; James Nicholas Dionne-Odom; Andres Azuero; Harleah Buck; Deborah Ejem; Kathryn L Burgio; Macy L Stockdill; Rodney Tucker; Salpy V Pamboukian; Jose Tallaj; Sally Engler; Konda Keebler; Sheri Tims; Raegan Durant; Keith M Swetz; Marie Bakitas Journal: J Pain Symptom Manage Date: 2021-02-05 Impact factor: 5.576
Authors: Carlo Guglielmini; Marco Baron Toaldo; Alex Chiesa; Barbara Contiero; Michele Berlanda; Helen Poser Journal: PLoS One Date: 2020-01-14 Impact factor: 3.240
Authors: Michael Urbich; Gary Globe; Krystallia Pantiri; Marieke Heisen; Craig Bennison; Heidi S Wirtz; Gian Luca Di Tanna Journal: Pharmacoeconomics Date: 2020-11 Impact factor: 4.981